Loading...

APC anti-mouse CD8a Antibody APC anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6dot7_APC_041106
C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
  • 53-6dot7_APC_041106
    C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
100711 25 µg DKK197
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100712 100 µg DKK624
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  2. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  3. Schuster M, et al. 2017. J Immunol. 199:920. PubMed
  4. Li X et al. 2019. Immunity. 50(3):576-590 . PubMed
  5. O'Malley G, et al. 2018. Cancer Immunol Res. 1.240277778. PubMed
  6. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  7. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  8. Saha S, et al. 2023. Sci Rep. 13:4609. PubMed
  9. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  10. Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed
  11. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  12. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  13. Zhang YT, et al. 2023. Front Immunol. 14:1085456. PubMed
  14. Zhang J, et al. 2023. Theranostics. 13:2226. PubMed
  15. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  16. He Y, et al. 2023. Biomolecules. 13:. PubMed
  17. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  18. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  19. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  20. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  21. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  22. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  23. Lan Y, et al. 2023. iScience. 26:106817. PubMed
  24. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  25. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  26. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  27. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  28. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  29. Behr FM, et al. 2021. Eur J Immunol. 51:151. PubMed
  30. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  31. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  32. Schenkel JM, et al. 2021. Immunity. 54:2338. PubMed
  33. Kragten NAM, et al. 2022. Eur J Immunol. 52:389. PubMed
  34. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  35. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  36. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  37. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  38. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  39. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  40. Marié IJ, et al. 2022. Bio Protoc. 12:e4438. PubMed
  41. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  42. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  43. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  44. Theofilatos D, et al. 2022. STAR Protoc. 3:101839. PubMed
  45. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  46. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  47. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  48. Morrow RJ, et al. 2022. Cells. 11: . PubMed
  49. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  50. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  51. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  52. Smith LA, et al. 2023. Front Oncol. 12:1031174. PubMed
  53. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  54. Kasuya T, et al. 2023. Sci Rep. 13:1653. PubMed
  55. Wang R, et al. 2023. NPJ Vaccines. 8:6. PubMed
  56. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  57. Zheng J, et al. 2023. Biomater Res. 27:9. PubMed
  58. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  59. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  60. Ye L, et al. 2022. Cell Metab. 34:595. PubMed
  61. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  62. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  63. Guo A, et al. 2022. Nature. 607:135. PubMed
  64. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  65. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  66. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  67. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  68. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  69. Li X, et al. 2023. J Clin Invest. 133:. PubMed
  70. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  71. Stone VM, et al. 2022. iScience. 25:105070. PubMed
  72. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  73. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  74. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  75. Bian L, et al. 2022. Front Immunol. 13:938598. PubMed
  76. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  77. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  78. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  79. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  80. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  81. Renrick AN, et al. 2021. Front Immunol. 607044:12. PubMed
  82. Wang D, et al. 2018. Immunity. 48:659. PubMed
  83. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  84. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  85. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  86. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  87. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  88. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  89. Iwasaki Y, et al. 2016. PLoS One. 11: 0158282. PubMed
  90. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  91. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  92. Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed
  93. Dong L, et al. 2021. Cancer Cell. . PubMed
  94. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  95. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  96. Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
  97. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  98. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  99. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  100. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  101. Li ZX, et al. 2022. Arch Virol. :. PubMed
  102. Ghosh S, et al. 2022. APL Bioeng. 6:036105. PubMed
  103. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  104. Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed
  105. Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed
  106. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  107. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  108. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  109. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  110. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  111. Tian H, et al. 2022. Cancer Sci. 113:875. PubMed
  112. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  113. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  114. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  115. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  116. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  117. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  118. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  119. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  120. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  121. Lee JH, et al. 2018. Transgenic Res. 27:241. PubMed
  122. Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed
  123. Felker A, Croy B 2016. J Leukoc Biol. 100: 645 - 655. PubMed
  124. Wagner V, et al. 2016. Sci Transl Med. 8: 366ra164. PubMed
  125. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  126. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  127. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  128. Yin Y, et al. 2021. ACS Nano. 15:14347. PubMed
  129. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  130. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  131. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  132. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  133. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  134. Li Y, et al. 2019. Oncol Rep. 41:2679. PubMed
  135. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  136. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  137. Frey N, et al. 2022. Nat Commun. 13:1804. PubMed
  138. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  139. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  140. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  141. Zhan CS, et al. 2020. FASEB J. 14006:34. PubMed
  142. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  143. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  144. Lebratti T, et al. 2021. eLife. 10:00. PubMed
  145. Eriksson E, et al. 2016. Gene Ther. 10.1038/gt.2016.80. PubMed
  146. Solanki A, et al. 2018. Development. 145. PubMed
  147. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  148. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  149. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  150. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  151. Yin Q, et al. 2015. PLoS One. 10: 0137808. PubMed
  152. Vieyra-Garcia P, et al. 2016. Clin Cancer Res. 22: 3328 - 3339. PubMed
  153. Matsumura K, et al. 2016. J Immunol. 197: 3233 - 3244. PubMed
  154. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  155. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  156. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  157. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  158. Poczobutt J, et al. 2016. J Immunol. 196: 891 - 901. PubMed
  159. Brummer G, et al. 2020. Oncogene. 39:2275. PubMed
  160. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  161. Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed
  162. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  163. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  164. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  165. Liu J, et al. 2019. J Exp Med. 216:656. PubMed
  166. Funk KE, et al. 2019. J Neuroinflammation. 16:22. PubMed
  167. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  168. Divan A, et al. 2018. PLoS One. 13:e0196893. PubMed
  169. He X, et al. 2021. Small. 17:e2007165. PubMed
  170. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  171. Katsinas N, et al. 2022. J Clin Med. 11:. PubMed
  172. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  173. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  174. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  175. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  176. Espinosa JR, et al. 2018. Front Immunol. 9:1371. PubMed
  177. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  178. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  179. Zheng Z, et al. 2020. Cell Death Dis. 0.684722222. PubMed
  180. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  181. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  182. Hoefflin R, et al. 2020. Nat Commun. 3.313194444. PubMed
  183. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  184. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  185. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  186. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  187. Leal AS, et al. 2019. Sci Rep. 5.286111111. PubMed
  188. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  189. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  190. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  191. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  192. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  193. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  194. He X, et al. 2022. Cancer Immunol Res. 10:314. PubMed
  195. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  196. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  197. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  198. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  199. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  200. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  201. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  202. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  203. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  204. Vidy A, et al. 2016. PLoS One. 11:e0165361. PubMed
  205. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  206. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  207. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  208. Takaku S, et al. 2020. Integr Cancer Ther. 19:1534735419900798. PubMed
  209. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  210. Medyouf H, et al. 2010. Blood. 115:1175. PubMed
  211. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  212. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  213. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  214. Latasa C, et al. 2016. PLoS One. 11: 0161216. PubMed
  215. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  216. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  217. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  218. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  219. Oka Y, et al. 2020. Sci Adv. 6:. PubMed
  220. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  221. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  222. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  223. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  224. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  225. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  226. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  227. Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
  228. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  229. Li YN, et al. 2022. Nat Commun. 13:4074. PubMed
  230. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  231. Lin W, et al. 2019. EBioMedicine. 49:133. PubMed
  232. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  233. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  234. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  235. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  236. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  237. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  238. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  239. Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed
  240. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  241. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  242. Lin YH, et al. 2018. Cancer Immunol Res. 0.25. PubMed
  243. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  244. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  245. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  246. Sun S, et al. 2013. J Immunol. 190:6209. PubMed
  247. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  248. Nanou A, et al. 2021. Cell Reports. 35(8):109168. PubMed
  249. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  250. Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed
  251. Feng Y, et al. 2022. J Nanobiotechnology. 20:193. PubMed
  252. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  253. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  254. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  255. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  256. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  257. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  258. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  259. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  260. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  261. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  262. Alexandre YO, et al. 2020. Cell Reports. 33(13):108567. PubMed
  263. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  264. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  265. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  266. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  267. Frazer GL, et al. 2021. J Cell Biol. 220:. PubMed
  268. Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
  269. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  270. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  271. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  272. Huber MK, et al. 2021. J Vis Exp. :. PubMed
  273. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  274. Ulaganathan VK, et al. 2020. Sci Rep. 10:8453. PubMed
  275. Li X, et al. 2017. Front Immunol. 8:1186. PubMed
  276. Schuster M, et al. 2019. Front Immunol. 10:1583. PubMed
  277. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  278. Fonderflick L, et al. 2022. Cells. 11:. PubMed
  279. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  280. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  281. He X, et al. 2021. J Immunother Cancer. 9:. PubMed
  282. Zheng Z, et al. 2021. Nat Commun. 12:6202. PubMed
  283. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  284. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  285. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  286. Zhang J, et al. 2018. Oncoimmunology. 7:e1461301. PubMed
  287. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  288. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  289. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  290. Tassi I, et al. 2014. J Immunol. 193:4303. PubMed
  291. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  292. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  293. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  294. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  295. Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed
  296. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  297. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  298. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  299. Harrison DK, et al. 2021. Transplantation. 105:540. PubMed
  300. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  301. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  302. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  303. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  304. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  305. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  306. Liu YW, et al. 2022. JCI Insight. 7:. PubMed
  307. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  308. Chen B, et al. 2021. Cell. 184:6262. PubMed
  309. Smith LK, et al. 2021. Elife. 10:. PubMed
  310. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  311. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  312. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  313. Konishi Y, et al. 2018. iScience. 10:98. PubMed
  314. Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed
  315. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  316. Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed
  317. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  318. Zhou P, et al. 2022. Mol Ther Oncolytics. 25:236. PubMed
  319. Zheng Y, et al. 2022. Transl Res. :. PubMed
  320. Funk KE, et al. 2021. Aging Cell. 20:e13412. PubMed
  321. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  322. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  323. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  324. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  325. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  326. Tseng SH, et al. 2021. J Biomed Sci. 28:63. PubMed
  327. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  328. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  329. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  330. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  331. Schuster M, et al. 2017. J Immunol. 199:920. PubMed
  332. Li X et al. 2019. Immunity. 50(3):576-590 . PubMed
  333. O'Malley G, et al. 2018. Cancer Immunol Res. 1.240277778. PubMed
  334. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  335. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  336. Saha S, et al. 2023. Sci Rep. 13:4609. PubMed
  337. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  338. Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed
  339. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  340. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  341. Zhang YT, et al. 2023. Front Immunol. 14:1085456. PubMed
  342. Zhang J, et al. 2023. Theranostics. 13:2226. PubMed
  343. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  344. He Y, et al. 2023. Biomolecules. 13:. PubMed
  345. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  346. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  347. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  348. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  349. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  350. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  351. Lan Y, et al. 2023. iScience. 26:106817. PubMed
  352. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  353. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  354. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  355. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  356. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  357. Behr FM, et al. 2021. Eur J Immunol. 51:151. PubMed
  358. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  359. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  360. Schenkel JM, et al. 2021. Immunity. 54:2338. PubMed
  361. Kragten NAM, et al. 2022. Eur J Immunol. 52:389. PubMed
  362. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  363. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  364. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  365. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  366. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  367. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  368. Marié IJ, et al. 2022. Bio Protoc. 12:e4438. PubMed
  369. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  370. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  371. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  372. Theofilatos D, et al. 2022. STAR Protoc. 3:101839. PubMed
  373. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  374. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  375. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  376. Morrow RJ, et al. 2022. Cells. 11: . PubMed
  377. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  378. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  379. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  380. Smith LA, et al. 2023. Front Oncol. 12:1031174. PubMed
  381. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  382. Kasuya T, et al. 2023. Sci Rep. 13:1653. PubMed
  383. Wang R, et al. 2023. NPJ Vaccines. 8:6. PubMed
  384. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  385. Zheng J, et al. 2023. Biomater Res. 27:9. PubMed
  386. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  387. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  388. Ye L, et al. 2022. Cell Metab. 34:595. PubMed
  389. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  390. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  391. Guo A, et al. 2022. Nature. 607:135. PubMed
  392. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  393. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  394. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  395. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  396. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  397. Li X, et al. 2023. J Clin Invest. 133:. PubMed
  398. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  399. Stone VM, et al. 2022. iScience. 25:105070. PubMed
  400. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  401. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  402. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  403. Bian L, et al. 2022. Front Immunol. 13:938598. PubMed
  404. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  405. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  406. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  407. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  408. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  409. Renrick AN, et al. 2021. Front Immunol. 607044:12. PubMed
  410. Wang D, et al. 2018. Immunity. 48:659. PubMed
  411. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  412. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  413. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  414. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  415. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  416. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  417. Iwasaki Y, et al. 2016. PLoS One. 11: 0158282. PubMed
  418. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  419. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  420. Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed
  421. Dong L, et al. 2021. Cancer Cell. . PubMed
  422. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  423. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  424. Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
  425. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  426. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  427. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  428. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  429. Li ZX, et al. 2022. Arch Virol. :. PubMed
  430. Ghosh S, et al. 2022. APL Bioeng. 6:036105. PubMed
  431. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  432. Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed
  433. Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed
  434. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  435. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  436. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  437. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  438. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  439. Tian H, et al. 2022. Cancer Sci. 113:875. PubMed
  440. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  441. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  442. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  443. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  444. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  445. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  446. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  447. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  448. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  449. Lee JH, et al. 2018. Transgenic Res. 27:241. PubMed
  450. Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed
  451. Felker A, Croy B 2016. J Leukoc Biol. 100: 645 - 655. PubMed
  452. Wagner V, et al. 2016. Sci Transl Med. 8: 366ra164. PubMed
  453. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  454. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  455. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  456. Yin Y, et al. 2021. ACS Nano. 15:14347. PubMed
  457. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  458. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  459. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  460. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  461. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  462. Li Y, et al. 2019. Oncol Rep. 41:2679. PubMed
  463. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  464. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  465. Frey N, et al. 2022. Nat Commun. 13:1804. PubMed
  466. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  467. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  468. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  469. Zhan CS, et al. 2020. FASEB J. 14006:34. PubMed
  470. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  471. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  472. Lebratti T, et al. 2021. eLife. 10:00. PubMed
  473. Eriksson E, et al. 2016. Gene Ther. 10.1038/gt.2016.80. PubMed
  474. Solanki A, et al. 2018. Development. 145. PubMed
  475. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  476. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  477. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  478. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  479. Yin Q, et al. 2015. PLoS One. 10: 0137808. PubMed
  480. Vieyra-Garcia P, et al. 2016. Clin Cancer Res. 22: 3328 - 3339. PubMed
  481. Matsumura K, et al. 2016. J Immunol. 197: 3233 - 3244. PubMed
  482. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  483. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  484. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  485. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  486. Poczobutt J, et al. 2016. J Immunol. 196: 891 - 901. PubMed
  487. Brummer G, et al. 2020. Oncogene. 39:2275. PubMed
  488. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  489. Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed
  490. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  491. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  492. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  493. Liu J, et al. 2019. J Exp Med. 216:656. PubMed
  494. Funk KE, et al. 2019. J Neuroinflammation. 16:22. PubMed
  495. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  496. Divan A, et al. 2018. PLoS One. 13:e0196893. PubMed
  497. He X, et al. 2021. Small. 17:e2007165. PubMed
  498. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  499. Katsinas N, et al. 2022. J Clin Med. 11:. PubMed
  500. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  501. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  502. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  503. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  504. Espinosa JR, et al. 2018. Front Immunol. 9:1371. PubMed
  505. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  506. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  507. Zheng Z, et al. 2020. Cell Death Dis. 0.684722222. PubMed
  508. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  509. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  510. Hoefflin R, et al. 2020. Nat Commun. 3.313194444. PubMed
  511. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  512. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  513. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  514. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  515. Leal AS, et al. 2019. Sci Rep. 5.286111111. PubMed
  516. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  517. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  518. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  519. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  520. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  521. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  522. He X, et al. 2022. Cancer Immunol Res. 10:314. PubMed
  523. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  524. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  525. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  526. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  527. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  528. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  529. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  530. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  531. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  532. Vidy A, et al. 2016. PLoS One. 11:e0165361. PubMed
  533. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  534. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  535. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  536. Takaku S, et al. 2020. Integr Cancer Ther. 19:1534735419900798. PubMed
  537. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  538. Medyouf H, et al. 2010. Blood. 115:1175. PubMed
  539. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  540. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  541. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  542. Latasa C, et al. 2016. PLoS One. 11: 0161216. PubMed
  543. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  544. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  545. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  546. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  547. Oka Y, et al. 2020. Sci Adv. 6:. PubMed
  548. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  549. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  550. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  551. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  552. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  553. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  554. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  555. Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
  556. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  557. Li YN, et al. 2022. Nat Commun. 13:4074. PubMed
  558. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  559. Lin W, et al. 2019. EBioMedicine. 49:133. PubMed
  560. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  561. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  562. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  563. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  564. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  565. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  566. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  567. Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed
  568. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  569. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  570. Lin YH, et al. 2018. Cancer Immunol Res. 0.25. PubMed
  571. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  572. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  573. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  574. Sun S, et al. 2013. J Immunol. 190:6209. PubMed
  575. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  576. Nanou A, et al. 2021. Cell Reports. 35(8):109168. PubMed
  577. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  578. Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed
  579. Feng Y, et al. 2022. J Nanobiotechnology. 20:193. PubMed
  580. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  581. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  582. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  583. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  584. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  585. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  586. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  587. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  588. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  589. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  590. Alexandre YO, et al. 2020. Cell Reports. 33(13):108567. PubMed
  591. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  592. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  593. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  594. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  595. Frazer GL, et al. 2021. J Cell Biol. 220:. PubMed
  596. Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
  597. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  598. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  599. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  600. Huber MK, et al. 2021. J Vis Exp. :. PubMed
  601. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  602. Ulaganathan VK, et al. 2020. Sci Rep. 10:8453. PubMed
  603. Li X, et al. 2017. Front Immunol. 8:1186. PubMed
  604. Schuster M, et al. 2019. Front Immunol. 10:1583. PubMed
  605. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  606. Fonderflick L, et al. 2022. Cells. 11:. PubMed
  607. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  608. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  609. He X, et al. 2021. J Immunother Cancer. 9:. PubMed
  610. Zheng Z, et al. 2021. Nat Commun. 12:6202. PubMed
  611. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  612. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  613. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  614. Zhang J, et al. 2018. Oncoimmunology. 7:e1461301. PubMed
  615. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  616. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  617. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  618. Tassi I, et al. 2014. J Immunol. 193:4303. PubMed
  619. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  620. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  621. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  622. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  623. Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed
  624. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  625. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  626. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  627. Harrison DK, et al. 2021. Transplantation. 105:540. PubMed
  628. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  629. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  630. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  631. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  632. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  633. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  634. Liu YW, et al. 2022. JCI Insight. 7:. PubMed
  635. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  636. Chen B, et al. 2021. Cell. 184:6262. PubMed
  637. Smith LK, et al. 2021. Elife. 10:. PubMed
  638. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  639. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  640. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  641. Konishi Y, et al. 2018. iScience. 10:98. PubMed
  642. Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed
  643. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  644. Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed
  645. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  646. Zhou P, et al. 2022. Mol Ther Oncolytics. 25:236. PubMed
  647. Zheng Y, et al. 2022. Transl Res. :. PubMed
  648. Funk KE, et al. 2021. Aging Cell. 20:e13412. PubMed
  649. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  650. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  651. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  652. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  653. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  654. Tseng SH, et al. 2021. J Biomed Sci. 28:63. PubMed
  655. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  656. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
RRID
AB_312750 (BioLegend Cat. No. 100711)
AB_312751 (BioLegend Cat. No. 100712)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC,IHC
FITC anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC-F,IP
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC,3D IHC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC,IHC,SB
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC,IP,Depletion,Block
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F,FC,3D IHC
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 515 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark Red™ 718 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
PE/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark PLUS UV395™ anti-mouse CD8a 53-6.7 FC
PerCP/Fire™ 780 anti-mouse CD8a 53-6.7 FC
Spark YG™ 581 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
Spark YG™ 593 anti-mouse CD8a (Flexi-Fluor™) Antibody 53-6.7 FC
StarBright UltraViolet 575 anti-mouse CD8a 53-6.7 FC
Spark PLUS V475™ anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 795 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 2    Revision Date: 01/21/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6dot7_APC_041106
C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
  • 53-6dot7_APC_041106
    C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
100711 25 µg DKK197
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100712 100 µg DKK624
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  2. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  3. Schuster M, et al. 2017. J Immunol. 199:920. PubMed
  4. Li X et al. 2019. Immunity. 50(3):576-590 . PubMed
  5. O'Malley G, et al. 2018. Cancer Immunol Res. 1.240277778. PubMed
  6. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  7. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  8. Saha S, et al. 2023. Sci Rep. 13:4609. PubMed
  9. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  10. Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed
  11. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  12. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  13. Zhang YT, et al. 2023. Front Immunol. 14:1085456. PubMed
  14. Zhang J, et al. 2023. Theranostics. 13:2226. PubMed
  15. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  16. He Y, et al. 2023. Biomolecules. 13:. PubMed
  17. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  18. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  19. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  20. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  21. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  22. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  23. Lan Y, et al. 2023. iScience. 26:106817. PubMed
  24. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  25. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  26. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  27. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  28. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  29. Behr FM, et al. 2021. Eur J Immunol. 51:151. PubMed
  30. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  31. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  32. Schenkel JM, et al. 2021. Immunity. 54:2338. PubMed
  33. Kragten NAM, et al. 2022. Eur J Immunol. 52:389. PubMed
  34. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  35. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  36. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  37. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  38. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  39. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  40. Marié IJ, et al. 2022. Bio Protoc. 12:e4438. PubMed
  41. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  42. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  43. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  44. Theofilatos D, et al. 2022. STAR Protoc. 3:101839. PubMed
  45. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  46. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  47. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  48. Morrow RJ, et al. 2022. Cells. 11: . PubMed
  49. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  50. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  51. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  52. Smith LA, et al. 2023. Front Oncol. 12:1031174. PubMed
  53. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  54. Kasuya T, et al. 2023. Sci Rep. 13:1653. PubMed
  55. Wang R, et al. 2023. NPJ Vaccines. 8:6. PubMed
  56. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  57. Zheng J, et al. 2023. Biomater Res. 27:9. PubMed
  58. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  59. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  60. Ye L, et al. 2022. Cell Metab. 34:595. PubMed
  61. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  62. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  63. Guo A, et al. 2022. Nature. 607:135. PubMed
  64. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  65. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  66. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  67. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  68. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  69. Li X, et al. 2023. J Clin Invest. 133:. PubMed
  70. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  71. Stone VM, et al. 2022. iScience. 25:105070. PubMed
  72. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  73. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  74. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  75. Bian L, et al. 2022. Front Immunol. 13:938598. PubMed
  76. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  77. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  78. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  79. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  80. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  81. Renrick AN, et al. 2021. Front Immunol. 607044:12. PubMed
  82. Wang D, et al. 2018. Immunity. 48:659. PubMed
  83. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  84. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  85. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  86. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  87. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  88. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  89. Iwasaki Y, et al. 2016. PLoS One. 11: 0158282. PubMed
  90. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  91. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  92. Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed
  93. Dong L, et al. 2021. Cancer Cell. . PubMed
  94. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  95. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  96. Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
  97. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  98. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  99. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  100. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  101. Li ZX, et al. 2022. Arch Virol. :. PubMed
  102. Ghosh S, et al. 2022. APL Bioeng. 6:036105. PubMed
  103. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  104. Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed
  105. Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed
  106. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  107. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  108. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  109. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  110. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  111. Tian H, et al. 2022. Cancer Sci. 113:875. PubMed
  112. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  113. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  114. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  115. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  116. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  117. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  118. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  119. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  120. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  121. Lee JH, et al. 2018. Transgenic Res. 27:241. PubMed
  122. Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed
  123. Felker A, Croy B 2016. J Leukoc Biol. 100: 645 - 655. PubMed
  124. Wagner V, et al. 2016. Sci Transl Med. 8: 366ra164. PubMed
  125. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  126. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  127. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  128. Yin Y, et al. 2021. ACS Nano. 15:14347. PubMed
  129. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  130. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  131. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  132. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  133. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  134. Li Y, et al. 2019. Oncol Rep. 41:2679. PubMed
  135. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  136. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  137. Frey N, et al. 2022. Nat Commun. 13:1804. PubMed
  138. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  139. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  140. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  141. Zhan CS, et al. 2020. FASEB J. 14006:34. PubMed
  142. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  143. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  144. Lebratti T, et al. 2021. eLife. 10:00. PubMed
  145. Eriksson E, et al. 2016. Gene Ther. 10.1038/gt.2016.80. PubMed
  146. Solanki A, et al. 2018. Development. 145. PubMed
  147. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  148. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  149. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  150. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  151. Yin Q, et al. 2015. PLoS One. 10: 0137808. PubMed
  152. Vieyra-Garcia P, et al. 2016. Clin Cancer Res. 22: 3328 - 3339. PubMed
  153. Matsumura K, et al. 2016. J Immunol. 197: 3233 - 3244. PubMed
  154. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  155. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  156. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  157. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  158. Poczobutt J, et al. 2016. J Immunol. 196: 891 - 901. PubMed
  159. Brummer G, et al. 2020. Oncogene. 39:2275. PubMed
  160. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  161. Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed
  162. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  163. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  164. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  165. Liu J, et al. 2019. J Exp Med. 216:656. PubMed
  166. Funk KE, et al. 2019. J Neuroinflammation. 16:22. PubMed
  167. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  168. Divan A, et al. 2018. PLoS One. 13:e0196893. PubMed
  169. He X, et al. 2021. Small. 17:e2007165. PubMed
  170. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  171. Katsinas N, et al. 2022. J Clin Med. 11:. PubMed
  172. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  173. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  174. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  175. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  176. Espinosa JR, et al. 2018. Front Immunol. 9:1371. PubMed
  177. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  178. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  179. Zheng Z, et al. 2020. Cell Death Dis. 0.684722222. PubMed
  180. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  181. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  182. Hoefflin R, et al. 2020. Nat Commun. 3.313194444. PubMed
  183. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  184. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  185. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  186. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  187. Leal AS, et al. 2019. Sci Rep. 5.286111111. PubMed
  188. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  189. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  190. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  191. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  192. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  193. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  194. He X, et al. 2022. Cancer Immunol Res. 10:314. PubMed
  195. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  196. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  197. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  198. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  199. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  200. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  201. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  202. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  203. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  204. Vidy A, et al. 2016. PLoS One. 11:e0165361. PubMed
  205. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  206. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  207. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  208. Takaku S, et al. 2020. Integr Cancer Ther. 19:1534735419900798. PubMed
  209. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  210. Medyouf H, et al. 2010. Blood. 115:1175. PubMed
  211. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  212. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  213. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  214. Latasa C, et al. 2016. PLoS One. 11: 0161216. PubMed
  215. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  216. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  217. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  218. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  219. Oka Y, et al. 2020. Sci Adv. 6:. PubMed
  220. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  221. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  222. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  223. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  224. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  225. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  226. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  227. Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
  228. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  229. Li YN, et al. 2022. Nat Commun. 13:4074. PubMed
  230. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  231. Lin W, et al. 2019. EBioMedicine. 49:133. PubMed
  232. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  233. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  234. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  235. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  236. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  237. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  238. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  239. Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed
  240. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  241. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  242. Lin YH, et al. 2018. Cancer Immunol Res. 0.25. PubMed
  243. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  244. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  245. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  246. Sun S, et al. 2013. J Immunol. 190:6209. PubMed
  247. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  248. Nanou A, et al. 2021. Cell Reports. 35(8):109168. PubMed
  249. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  250. Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed
  251. Feng Y, et al. 2022. J Nanobiotechnology. 20:193. PubMed
  252. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  253. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  254. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  255. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  256. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  257. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  258. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  259. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  260. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  261. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  262. Alexandre YO, et al. 2020. Cell Reports. 33(13):108567. PubMed
  263. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  264. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  265. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  266. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  267. Frazer GL, et al. 2021. J Cell Biol. 220:. PubMed
  268. Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
  269. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  270. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  271. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  272. Huber MK, et al. 2021. J Vis Exp. :. PubMed
  273. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  274. Ulaganathan VK, et al. 2020. Sci Rep. 10:8453. PubMed
  275. Li X, et al. 2017. Front Immunol. 8:1186. PubMed
  276. Schuster M, et al. 2019. Front Immunol. 10:1583. PubMed
  277. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  278. Fonderflick L, et al. 2022. Cells. 11:. PubMed
  279. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  280. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  281. He X, et al. 2021. J Immunother Cancer. 9:. PubMed
  282. Zheng Z, et al. 2021. Nat Commun. 12:6202. PubMed
  283. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  284. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  285. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  286. Zhang J, et al. 2018. Oncoimmunology. 7:e1461301. PubMed
  287. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  288. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  289. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  290. Tassi I, et al. 2014. J Immunol. 193:4303. PubMed
  291. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  292. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  293. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  294. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  295. Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed
  296. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  297. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  298. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  299. Harrison DK, et al. 2021. Transplantation. 105:540. PubMed
  300. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  301. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  302. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  303. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  304. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  305. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  306. Liu YW, et al. 2022. JCI Insight. 7:. PubMed
  307. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  308. Chen B, et al. 2021. Cell. 184:6262. PubMed
  309. Smith LK, et al. 2021. Elife. 10:. PubMed
  310. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  311. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  312. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  313. Konishi Y, et al. 2018. iScience. 10:98. PubMed
  314. Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed
  315. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  316. Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed
  317. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  318. Zhou P, et al. 2022. Mol Ther Oncolytics. 25:236. PubMed
  319. Zheng Y, et al. 2022. Transl Res. :. PubMed
  320. Funk KE, et al. 2021. Aging Cell. 20:e13412. PubMed
  321. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  322. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  323. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  324. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  325. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  326. Tseng SH, et al. 2021. J Biomed Sci. 28:63. PubMed
  327. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  328. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  329. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  330. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  331. Schuster M, et al. 2017. J Immunol. 199:920. PubMed
  332. Li X et al. 2019. Immunity. 50(3):576-590 . PubMed
  333. O'Malley G, et al. 2018. Cancer Immunol Res. 1.240277778. PubMed
  334. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  335. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  336. Saha S, et al. 2023. Sci Rep. 13:4609. PubMed
  337. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  338. Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed
  339. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  340. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  341. Zhang YT, et al. 2023. Front Immunol. 14:1085456. PubMed
  342. Zhang J, et al. 2023. Theranostics. 13:2226. PubMed
  343. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  344. He Y, et al. 2023. Biomolecules. 13:. PubMed
  345. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  346. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  347. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  348. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  349. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  350. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  351. Lan Y, et al. 2023. iScience. 26:106817. PubMed
  352. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  353. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  354. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  355. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  356. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  357. Behr FM, et al. 2021. Eur J Immunol. 51:151. PubMed
  358. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  359. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  360. Schenkel JM, et al. 2021. Immunity. 54:2338. PubMed
  361. Kragten NAM, et al. 2022. Eur J Immunol. 52:389. PubMed
  362. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  363. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  364. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  365. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  366. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  367. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  368. Marié IJ, et al. 2022. Bio Protoc. 12:e4438. PubMed
  369. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  370. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  371. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  372. Theofilatos D, et al. 2022. STAR Protoc. 3:101839. PubMed
  373. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  374. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  375. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  376. Morrow RJ, et al. 2022. Cells. 11: . PubMed
  377. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  378. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  379. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  380. Smith LA, et al. 2023. Front Oncol. 12:1031174. PubMed
  381. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  382. Kasuya T, et al. 2023. Sci Rep. 13:1653. PubMed
  383. Wang R, et al. 2023. NPJ Vaccines. 8:6. PubMed
  384. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  385. Zheng J, et al. 2023. Biomater Res. 27:9. PubMed
  386. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  387. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  388. Ye L, et al. 2022. Cell Metab. 34:595. PubMed
  389. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  390. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  391. Guo A, et al. 2022. Nature. 607:135. PubMed
  392. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  393. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  394. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  395. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  396. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  397. Li X, et al. 2023. J Clin Invest. 133:. PubMed
  398. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  399. Stone VM, et al. 2022. iScience. 25:105070. PubMed
  400. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  401. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  402. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  403. Bian L, et al. 2022. Front Immunol. 13:938598. PubMed
  404. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  405. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  406. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  407. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  408. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  409. Renrick AN, et al. 2021. Front Immunol. 607044:12. PubMed
  410. Wang D, et al. 2018. Immunity. 48:659. PubMed
  411. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  412. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  413. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  414. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  415. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  416. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  417. Iwasaki Y, et al. 2016. PLoS One. 11: 0158282. PubMed
  418. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  419. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  420. Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed
  421. Dong L, et al. 2021. Cancer Cell. . PubMed
  422. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  423. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  424. Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
  425. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  426. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  427. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  428. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  429. Li ZX, et al. 2022. Arch Virol. :. PubMed
  430. Ghosh S, et al. 2022. APL Bioeng. 6:036105. PubMed
  431. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  432. Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed
  433. Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed
  434. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  435. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  436. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  437. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  438. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  439. Tian H, et al. 2022. Cancer Sci. 113:875. PubMed
  440. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  441. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  442. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  443. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  444. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  445. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  446. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  447. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  448. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  449. Lee JH, et al. 2018. Transgenic Res. 27:241. PubMed
  450. Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed
  451. Felker A, Croy B 2016. J Leukoc Biol. 100: 645 - 655. PubMed
  452. Wagner V, et al. 2016. Sci Transl Med. 8: 366ra164. PubMed
  453. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  454. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  455. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  456. Yin Y, et al. 2021. ACS Nano. 15:14347. PubMed
  457. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  458. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  459. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  460. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  461. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  462. Li Y, et al. 2019. Oncol Rep. 41:2679. PubMed
  463. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  464. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  465. Frey N, et al. 2022. Nat Commun. 13:1804. PubMed
  466. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  467. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  468. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  469. Zhan CS, et al. 2020. FASEB J. 14006:34. PubMed
  470. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  471. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  472. Lebratti T, et al. 2021. eLife. 10:00. PubMed
  473. Eriksson E, et al. 2016. Gene Ther. 10.1038/gt.2016.80. PubMed
  474. Solanki A, et al. 2018. Development. 145. PubMed
  475. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  476. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  477. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  478. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  479. Yin Q, et al. 2015. PLoS One. 10: 0137808. PubMed
  480. Vieyra-Garcia P, et al. 2016. Clin Cancer Res. 22: 3328 - 3339. PubMed
  481. Matsumura K, et al. 2016. J Immunol. 197: 3233 - 3244. PubMed
  482. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  483. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  484. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  485. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  486. Poczobutt J, et al. 2016. J Immunol. 196: 891 - 901. PubMed
  487. Brummer G, et al. 2020. Oncogene. 39:2275. PubMed
  488. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  489. Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed
  490. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  491. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  492. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  493. Liu J, et al. 2019. J Exp Med. 216:656. PubMed
  494. Funk KE, et al. 2019. J Neuroinflammation. 16:22. PubMed
  495. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  496. Divan A, et al. 2018. PLoS One. 13:e0196893. PubMed
  497. He X, et al. 2021. Small. 17:e2007165. PubMed
  498. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  499. Katsinas N, et al. 2022. J Clin Med. 11:. PubMed
  500. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  501. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  502. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  503. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  504. Espinosa JR, et al. 2018. Front Immunol. 9:1371. PubMed
  505. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  506. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  507. Zheng Z, et al. 2020. Cell Death Dis. 0.684722222. PubMed
  508. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  509. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  510. Hoefflin R, et al. 2020. Nat Commun. 3.313194444. PubMed
  511. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  512. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  513. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  514. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  515. Leal AS, et al. 2019. Sci Rep. 5.286111111. PubMed
  516. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  517. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  518. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  519. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  520. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  521. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  522. He X, et al. 2022. Cancer Immunol Res. 10:314. PubMed
  523. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  524. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  525. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  526. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  527. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  528. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  529. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  530. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  531. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  532. Vidy A, et al. 2016. PLoS One. 11:e0165361. PubMed
  533. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  534. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  535. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  536. Takaku S, et al. 2020. Integr Cancer Ther. 19:1534735419900798. PubMed
  537. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  538. Medyouf H, et al. 2010. Blood. 115:1175. PubMed
  539. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  540. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  541. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  542. Latasa C, et al. 2016. PLoS One. 11: 0161216. PubMed
  543. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  544. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  545. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  546. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  547. Oka Y, et al. 2020. Sci Adv. 6:. PubMed
  548. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  549. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  550. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  551. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  552. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  553. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  554. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  555. Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
  556. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  557. Li YN, et al. 2022. Nat Commun. 13:4074. PubMed
  558. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  559. Lin W, et al. 2019. EBioMedicine. 49:133. PubMed
  560. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  561. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  562. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  563. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  564. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  565. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  566. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  567. Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed
  568. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  569. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  570. Lin YH, et al. 2018. Cancer Immunol Res. 0.25. PubMed
  571. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  572. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  573. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  574. Sun S, et al. 2013. J Immunol. 190:6209. PubMed
  575. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  576. Nanou A, et al. 2021. Cell Reports. 35(8):109168. PubMed
  577. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  578. Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed
  579. Feng Y, et al. 2022. J Nanobiotechnology. 20:193. PubMed
  580. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  581. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  582. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  583. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  584. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  585. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  586. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  587. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  588. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  589. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  590. Alexandre YO, et al. 2020. Cell Reports. 33(13):108567. PubMed
  591. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  592. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  593. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  594. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  595. Frazer GL, et al. 2021. J Cell Biol. 220:. PubMed
  596. Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
  597. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  598. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  599. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  600. Huber MK, et al. 2021. J Vis Exp. :. PubMed
  601. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  602. Ulaganathan VK, et al. 2020. Sci Rep. 10:8453. PubMed
  603. Li X, et al. 2017. Front Immunol. 8:1186. PubMed
  604. Schuster M, et al. 2019. Front Immunol. 10:1583. PubMed
  605. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  606. Fonderflick L, et al. 2022. Cells. 11:. PubMed
  607. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  608. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  609. He X, et al. 2021. J Immunother Cancer. 9:. PubMed
  610. Zheng Z, et al. 2021. Nat Commun. 12:6202. PubMed
  611. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  612. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  613. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  614. Zhang J, et al. 2018. Oncoimmunology. 7:e1461301. PubMed
  615. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  616. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  617. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  618. Tassi I, et al. 2014. J Immunol. 193:4303. PubMed
  619. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  620. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  621. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  622. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  623. Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed
  624. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  625. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  626. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  627. Harrison DK, et al. 2021. Transplantation. 105:540. PubMed
  628. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  629. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  630. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  631. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  632. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  633. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  634. Liu YW, et al. 2022. JCI Insight. 7:. PubMed
  635. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  636. Chen B, et al. 2021. Cell. 184:6262. PubMed
  637. Smith LK, et al. 2021. Elife. 10:. PubMed
  638. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  639. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  640. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  641. Konishi Y, et al. 2018. iScience. 10:98. PubMed
  642. Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed
  643. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  644. Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed
  645. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  646. Zhou P, et al. 2022. Mol Ther Oncolytics. 25:236. PubMed
  647. Zheng Y, et al. 2022. Transl Res. :. PubMed
  648. Funk KE, et al. 2021. Aging Cell. 20:e13412. PubMed
  649. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  650. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  651. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  652. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  653. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  654. Tseng SH, et al. 2021. J Biomed Sci. 28:63. PubMed
  655. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  656. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
RRID
AB_312750 (BioLegend Cat. No. 100711)
AB_312751 (BioLegend Cat. No. 100712)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC,IHC
FITC anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC-F,IP
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC,3D IHC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC,IHC,SB
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC,IP,Depletion,Block
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F,FC,3D IHC
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 515 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark Red™ 718 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
PE/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark PLUS UV395™ anti-mouse CD8a 53-6.7 FC
PerCP/Fire™ 780 anti-mouse CD8a 53-6.7 FC
Spark YG™ 581 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
Spark YG™ 593 anti-mouse CD8a (Flexi-Fluor™) Antibody 53-6.7 FC
StarBright UltraViolet 575 anti-mouse CD8a 53-6.7 FC
Spark PLUS V475™ anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 795 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 2    Revision Date: 01/21/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account